RxNorm 731184 NDC Crossover
darbepoetin alfa 500 MCG in 1 ML Prefilled Syringe
Related NDC Codes to RxNorm Concept 731184
The following NDC codes crossover to the RxNorm Concept 731184. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Status | |
---|---|---|---|---|---|---|---|
55513-002 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-003 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-004 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-005 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-006 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-021 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-023 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-025 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-027 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-028 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-032 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-057 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-098 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-110 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
55513-111 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE |